Last updated on March 2019

Mitoxantrone and Clofarabine for Treatment of Recurrent NHL or Acute Leukemia


Brief description of study

The combination of mitoxantrone and clofarabine as reinduction therapy will be safe, well tolerated and effective in children, adolescents and young adults with poor risk refractory/relapsed acute leukemia and high grade non-Hodgkin lymphoma (NHL).

Clinical Study Identifier: NCT01842672

Find a site near you

Start Over

Levine Children's Hospital

Charlotte, NC United States
  Connect »

New York Medical College

Valhalla, NY United States
  Connect »